1st Quarter - Report

BIOGEN for BIOGEN

Firm
Client
Income
—
Expenses
$405,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

1) Support for strong IP protections for biologics and pharmaceuticals, consistent with US law, to be included in the Trans-Pacific Partnership (TPP) trade agreement. 2) Support for strong IP protections for biologics and pharmaceuticals, consistent with US law, to be included in the US-EU (TTIP) trade agreement.

LobbyistCovered position, as disclosed
ADAM GLUCK Staff, Senate HELP Committee
KATHLEEN TREGONING Staff, House Ways and Means Committee

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

1) Support domestic and international corporate tax policies which protect and incentivize US-based research and manufacturing jobs. 2) Support maintaining the orphan drug tax credit. 3) Support maintaining the Research and Development tax credit.

LobbyistCovered position, as disclosed
ADAM GLUCK Staff, Senate HELP Committee
KATHLEEN TREGONING Staff, House Ways and Means Committee

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

Patent legislation H.R. 3309 and S. 1720 promoting appropriate rules for pleasdings and discovery in patent cases for both drugs and biologics

LobbyistCovered position, as disclosed
ADAM GLUCK Staff, Senate HELP Committee
KATHLEEN TREGONING Staff, House Ways and Means Committee

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3309 (113th), S. 1720 (113th)

Health Issues HCR

1) Support 340B anti-fraud and program integrity policies. 3) Support policies to improve National Newborn Screening Program, including H.R. 1281 and S. 1417 3) ACA implementation oversight to protect patient access to medical specialists in new health care insurance exchanges.

LobbyistCovered position, as disclosed
ADAM GLUCK Staff, Senate HELP Committe
KATHLEEN TREGONING Staff, House Ways and Means Committee

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1281 (113th), S. 1417 (113th)

Medicare/Medicaid MMM

1) Opposition to rebates or price controls in the Medicare Part D program. 2) Opposition to changes to the ASP+6 Medicare Part B reimbursement system.

LobbyistCovered position, as disclosed
ADAM GLUCK Staff, Senate HELP Committee
KATHLEEN TREGONING Staff, House Ways and Means Committee

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.